Similar articles

• Immunotherapy with a ragweed vaccine.

  Seymour SM, Chowdhury BA. Seymour SM, et al. N Engl J Med. 2007 Jan 4;356(1):86; author reply 87. doi: 10.1056/NEJMc063014. N Engl J Med. 2007. PMID: 17202461 No abstract available.
• Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.

  Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D; Immune Tolerance Network Group. Creticos PS, et al. N Engl J Med. 2006 Oct 5;355(14):1445-55. doi: 10.1056/NEJMoa052916. N Engl J Med. 2006. PMID: 17021320 Clinical Trial.
• Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.

  Simons FE, Shikishima Y, Van Nest G, Eiden JJ, HayGlass KT. Simons FE, et al. J Allergy Clin Immunol. 2004 Jun;113(6):1144-51. doi: 10.1016/j.jaci.2004.03.003. J Allergy Clin Immunol. 2004. PMID: 15208597 Clinical Trial.
• Weed pollen allergens.

  Mohapatra SS, Lockey RF, Polo F. Mohapatra SS, et al. Clin Allergy Immunol. 2008;21:127-39. Clin Allergy Immunol. 2008. PMID: 18828502 Review. No abstract available.
• Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis.

  Nelson HS. Nelson HS. Expert Rev Clin Immunol. 2018 Dec;14(12):1003-1011. doi: 10.1080/1744666X.2018.1538788. Epub 2018 Nov 8. Expert Rev Clin Immunol. 2018. PMID: 30345820 Review.